Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $58.6, along ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $446.4 million specializing in mRNA therapeutics and vaccines, stands at ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Arcturus Therapeutics (NASDAQ:ARCT) in the last three months. The table below summarizes ...

Arcturus Therapeutics Holdings Inc is an RNA ... This article was generated by Benzinga's automated content engine and reviewed by an editor.

Monster trucks are truly beastly machines. With their wild paint jobs, massive tires, and unmistakable roar, it's impossible not to keep your eyes glued to them as they jump, flip (either on ...

Both engines of the aircraft involved in last month’s fatal Jeju Air crash in South Korea were found with bird remnants, though it remains unclear how much damage each sustained before the plane ...

The Havok physics engine was behind all those fond memories, powering the destruction of my hopes and dreams on screen and culminating in Newtonian masterpieces like Red Faction, Super Smash Bros ...

Why it matters: Havok, the Irish-based software maker whose physics engine can be found in countless blockbuster games, has published its first new technology demo on YouTube in a decade.

HC Wainwright reaffirmed a “buy” rating and issued a $63.00 price objective on shares of Arcturus Therapeutics in a research note on Monday, January 13th. Cantor Fitzgerald reiterated an ...